Class I phosphoinositide 3-kinase (PI3K) regulatory subunits and their roles in signaling and disease

Adv Biol Regul. 2020 Jan:75:100657. doi: 10.1016/j.jbior.2019.100657. Epub 2019 Sep 28.

Abstract

The Class I phosphoinositide 3-kinases (PI3Ks) are a group of heterodimeric lipid kinases that regulate crucial cellular processes including proliferation, survival, growth, and metabolism. The diversity in functions controlled by the various catalytic isoforms (p110α, p110β, p110δ, and p110γ) depends on their abilities to be activated by distinct stimuli such as receptor tyrosine kinases (RTKs), G-protein coupled receptors (GPCRs), and the Ras family of small G-proteins. A major factor determining the ability of each p110 enzyme to be activated is the presence of regulatory binding partners. Given the overwhelming evidence for the involvement of PI3Ks in diseases such as cancer, inflammation, immunodeficiency and diabetes, an understanding of how these regulatory proteins influence PI3K function is essential. This article highlights research deciphering the role of regulatory subunits in PI3K signaling and their involvement in human disease.

Keywords: PI3K; PIK3CA; PIK3R1; Phosphoinositide 3-kinase; p110; p85.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Humans
  • Inflammation / enzymology
  • Neoplasm Proteins / metabolism*
  • Neoplasms / enzymology*
  • Phosphatidylinositol 3-Kinases / metabolism*
  • Signal Transduction*

Substances

  • Neoplasm Proteins